AI Tool Comparison
Comparing as AI Medical Research & Clinical Decision SupportGlass Health vs Doximity
Compare features, pricing, pros & cons, and user ratings to decide which AI tool is best for your needs.
Glass Health
VS
Doximity
Verdict by Category
Detailed category analysis is not available for this comparison.
Detailed Comparison
Feature
Glass Health
Doximity
Pricing
FreemiumGlass Health publishes its pricing transparently:
Lite (Free): Basic clinical decision support and differential diagnosis with usage limits.
Starter at $20/month: Expanded ambient scribing and CDS features for regular clinical use.
Pro at $90/month: Extended ambient scribing, extended CDS, and extended Deep Reasoning for complex cases.
Max at $200/month: Maximum all features, priority response processing, and full EHR integration via SMART on FHIR (Epic, eClinicalWorks, athenahealth, Elation). Team plans available for group practices.
FreemiumDoximity is free for all verified US healthcare professionals. Physicians, nurse practitioners, physician assistants, and medical students can access the full platform including Doximity Ask, Scribe, Dialer, secure messaging, and clinical news feed at no cost after NPI credential verification.
Doximity monetizes through B2B enterprise clients: pharmaceutical manufacturers, health systems, and medical recruiting firms pay to access and engage with Doximity's verified physician network through sponsored content, targeted outreach, and workflow integrations.
Enterprise pricing for health system and pharma clients is not publicly disclosed. Contact Doximity through doximity.com for enterprise partnership and B2B pricing inquiries.
Categories
AI Healthcare ToolsAI Research & Education Tools
AI Healthcare ToolsAI Research & Education ToolsAI Chatbots
Summary
AI clinical decision support + ambient scribing in one workflow — real-time CDS and transparent pricing
America's largest physician network with free Clinical AI — Ask, Scribe, Dialer for 3M+ clinicians
Glass Health Pros & Cons
Pros
- Only platform combining real-time Ambient CDS and ambient scribing in one unified clinical workflow
- Transparent published pricing (free to $200/mo) — rare in a category where most require sales conversations
- Evolving differential diagnosis during encounter — AI thinking partner not just a documentation tool
- SMART on FHIR EHR integration at Max tier — works natively inside Epic, eClinicalWorks, athenahealth, Elation
- Backed by Y Combinator, Initialized Capital, and Breyer Capital — strong early-stage pedigree
- Google for Startups AI First Accelerator alumnus (Apr 2024)
- Free Lite plan — no cost barrier for clinicians to evaluate real-time clinical AI support
Cons
- Early-stage company with ~$6.5M total funding — small vs OpenEvidence ($250M) or Doximity ($644M revenue)
- Max plan EHR integration at $200/month expensive for solo practitioners
- English-only — not suitable for multilingual clinical practices
- AI-generated differential not physician-reviewed like OpenEvidence or UpToDate content
- Less comprehensive clinical content than UpToDate’s 13,000+ expert-authored topics
- Small team (~7 employees) — limited engineering resources for product roadmap
Doximity Pros & Cons
Pros
- 85%+ of US physicians already on the platform — unmatched distribution advantage for AI clinical tools
- PeerCheck — 10,000-11,000 physician reviewers continuously validate AI answers, unique trust mechanism
- All AI tools completely free for verified US clinicians — zero budget barrier for adoption
- $644.9M FY2026 revenue, NASDAQ: DOCS — financially stable with strong margins (33% net income)
- Pathway Medical acquisition ($63M, Aug 2025) added physician-built clinical evidence dataset to Ask
- 300,000+ unique AI users in Q3 FY2026 — rapid AI adoption within existing physician network
- CEO declared 2026 an AI investment year — aggressive product roadmap with new physician-led AI agents
Cons
- OpenEvidence sued Doximity in June 2025 alleging reverse engineering of proprietary AI technology — legal risk
- AI products currently generate no direct revenue — monetization via B2B pharma/health system clients
- AI tools US-only — not available to international clinicians
- PeerCheck physician review relies on volunteer physician network — coverage can vary by specialty
- Doximity Scribe competes with established ambient documentation tools like DAX Copilot and Nabla with less clinical track record
- Enterprise AI pricing not publicly disclosed